Nektar Therapeutics (NKTR)

69.72 +1.30 (+1.90%) USD  |  NASDAQ  |  Feb 25, 14:49
More

Nektar Therapeutics Accrued Expenses (Quarterly)

Accrued Expenses (Quarterly) Chart

View Accrued Expenses (Quarterly) for NKTR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Accrued Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Accrued Expenses (Quarterly) Range, Past 5 Years

View Accrued Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Accrued Expenses (Quarterly) Benchmarks

View Accrued Expenses (Quarterly) Benchmarks
Start Trial
Rigel Pharmaceuticals, Inc. Upgrade
Insmed, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Ironwood Pharmaceuticals, Inc. Upgrade
Lyell Immunopharma, Inc. Upgrade